Lung Cancer Screening Implementation Project in the Brazilian Public Health Care System (LUSIP) - LUSIP

Study identifier:D133FR00225

ClinicalTrials.gov identifier:NCT07279948

EudraCT identifier:N/A

CTIS identifier:N/A

Will Be Recruiting

Official Title

Lung Cancer Screening Implementation Project in the Brazilian Public Health Care System (LUSIP)

Medical condition

lung cancer

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

477

Study type

Observational

Age

50 Years - 80 Years

Date

Study Start Date: 30 Oct 2026
Estimated Primary Completion Date: 31 Jan 2027
Estimated Study Completion Date: 31 Jan 2027

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Sept 2026 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria